NCT06234319View on ClinicalTrials.gov

CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain Glioma

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Glioma
Interventions
DIAGNOSTIC_TEST

CXCR4

Patients with clinical suspected primary glioma will receive a CXCR4 PET imaging.

Trial Locations (1)

400000

RECRUITING

Department of Nuclear Medicine, Daping Hospital of Army Medical University, Chongqing

All Listed Sponsors
lead

Xiao Chen

OTHER